Terms: = Colorectal cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659
11 results:
1. IMMUNOEXPRESSION OF dek AND PHOSPHO-P38 PROTEINS IN RECTAL cancer BEFORE CHEMORADIATION THERAPY.
Tadokoro RB; Cardili L; Artigiani Neto R; Paiotti APR; Oshima CTF; Forones NM
Arq Gastroenterol; 2022; 59(3):414-420. PubMed ID: 36102441
[TBL] [Abstract] [Full Text] [Related]
2. Very Long-Term Treatment with a
Mutoh M; Yoshimura K; Fujii G; Nakamura T; Takeshita T; Wakabayashi K; Sakai T; Ishikawa H
Nutrients; 2020 May; 12(6):. PubMed ID: 32485893
[TBL] [Abstract] [Full Text] [Related]
3. Bioinspired gold nanoparticles decorated reduced graphene oxide nanocomposite using Syzygium cumini seed extract: Evaluation of its biological applications.
Kadiyala NK; Mandal BK; Ranjan S; Dasgupta N
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():191-205. PubMed ID: 30274051
[TBL] [Abstract] [Full Text] [Related]
4. The potential predictive value of dek expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
[TBL] [Abstract] [Full Text] [Related]
5. Epithelial‑mesenchymal transition in colorectal carcinoma cells is mediated by dek/IMP3.
You S; Guan Y; Li W
Mol Med Rep; 2018 Jan; 17(1):1065-1070. PubMed ID: 29115492
[TBL] [Abstract] [Full Text] [Related]
6. Novel ent-Kaurane Diterpenoid from Rubus corchorifolius L. f. Inhibits Human Colon cancer Cell Growth via Inducing Cell Cycle Arrest and Apoptosis.
Chen X; Wu X; Ouyang W; Gu M; Gao Z; Song M; Chen Y; Lin Y; Cao Y; Xiao H
J Agric Food Chem; 2017 Mar; 65(8):1566-1573. PubMed ID: 28169543
[TBL] [Abstract] [Full Text] [Related]
7. dek is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms underlying cancer growth and apoptosis by dek overexpression in colorectal cancer.
Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
[TBL] [Abstract] [Full Text] [Related]
9. Association of sedentary behavior with the expression levels of biomarkers in colorectal cancer: clinical analysis of 228 patients.
Yu T; Lu Q; Ou X; Cao D; Yu Q
Tohoku J Exp Med; 2014 Mar; 232(3):167-76. PubMed ID: 24621823
[TBL] [Abstract] [Full Text] [Related]
10. dek over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract] [Full Text] [Related]
11. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and dek for degradation.
Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
[TBL] [Abstract] [Full Text] [Related]
